Literature DB >> 29414774

Hexokinase 2 and nuclear factor erythroid 2-related factor 2 transcriptionally coactivate xanthine oxidoreductase expression in stressed glioma cells.

Touseef Sheikh1, Piyushi Gupta1, Pruthvi Gowda1, Shruti Patrick1, Ellora Sen2.   

Abstract

A dynamic network of metabolic adaptations, inflammatory responses, and redox homeostasis is known to drive tumor progression. A considerable overlap among these processes exists, but several of their key regulators remain unknown. To this end, here we investigated the role of the proinflammatory cytokine IL-1β in connecting these processes in glioma cells. We found that glucose starvation sensitizes glioma cells to IL-1β-induced apoptosis in a manner that depended on reactive oxygen species (ROS). Although IL-1β-induced JNK had no effect on cell viability under glucose deprivation, it mediated nuclear translocation of hexokinase 2 (HK2). This event was accompanied by increases in the levels of sirtuin 6 (SIRT6), nuclear factor erythroid 2-related factor 2 (Nrf2), and xanthine oxidoreductase (XOR). SIRT6 not only induced ROS-mediated cell death but also facilitated nuclear Nrf2-HK2 interaction. Recruitment of the Nrf2-HK2 complex to the ARE site on XOR promoter regulated its expression. Importantly, HK2 served as transcriptional coactivator of Nrf2 to regulate XOR expression, indicated by decreased XOR levels in siRNA-mediated Nrf2 and HK2 knockdown experiments. Our results highlight a non-metabolic role of HK2 as transcriptional coactivator of Nrf2 to regulate XOR expression under conditions of proinflammatory and metabolic stresses. Our insights also underscore the importance of nuclear activities of HK2 in the regulation of genes involved in redox homeostasis.
© 2018 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  SIRT6; c-Jun N-terminal kinase (JNK); glucose; hexokinase; interleukin 1 (IL-1); nuclear factor 2 (erythroid-derived 2-like factor) (NFE2L2) (Nrf2)

Mesh:

Substances:

Year:  2018        PMID: 29414774      PMCID: PMC5880127          DOI: 10.1074/jbc.M117.816785

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  44 in total

1.  NRF2 blockade suppresses colon tumor angiogenesis by inhibiting hypoxia-induced activation of HIF-1α.

Authors:  Tae-Hyoung Kim; Eu-gene Hur; Su-Jin Kang; Jung-Ae Kim; Dinesh Thapa; You Mie Lee; Sae Kwang Ku; Yunjin Jung; Mi-Kyoung Kwak
Journal:  Cancer Res       Date:  2011-01-28       Impact factor: 12.701

2.  IL-1 resets glucose homeostasis at central levels.

Authors:  Adriana Del Rey; Eduardo Roggero; Anke Randolf; Carolina Mahuad; Samuel McCann; Valeria Rettori; Hugo O Besedovsky
Journal:  Proc Natl Acad Sci U S A       Date:  2006-10-11       Impact factor: 11.205

3.  A role for mitochondria in NLRP3 inflammasome activation.

Authors:  Rongbin Zhou; Amir S Yazdi; Philippe Menu; Jürg Tschopp
Journal:  Nature       Date:  2010-12-01       Impact factor: 49.962

4.  SIRT6 regulated nucleosomal occupancy affects Hexokinase 2 expression.

Authors:  Piyushi Gupta; Touseef Sheikh; Ellora Sen
Journal:  Exp Cell Res       Date:  2017-05-04       Impact factor: 3.905

5.  Production of large amounts of hydrogen peroxide by human tumor cells.

Authors:  T P Szatrowski; C F Nathan
Journal:  Cancer Res       Date:  1991-02-01       Impact factor: 12.701

6.  TNFα driven HIF-1α-hexokinase II axis regulates MHC-I cluster stability through actin cytoskeleton.

Authors:  Sadashib Ghosh; Piyushi Gupta; Ellora Sen
Journal:  Exp Cell Res       Date:  2015-11-17       Impact factor: 3.905

7.  Hexokinase Is an Innate Immune Receptor for the Detection of Bacterial Peptidoglycan.

Authors:  Andrea J Wolf; Christopher N Reyes; Wenbin Liang; Courtney Becker; Kenichi Shimada; Matthew L Wheeler; Hee Cheol Cho; Narcis I Popescu; K Mark Coggeshall; Moshe Arditi; David M Underhill
Journal:  Cell       Date:  2016-06-30       Impact factor: 41.582

8.  The NAD+-dependent histone deacetylase SIRT6 promotes cytokine production and migration in pancreatic cancer cells by regulating Ca2+ responses.

Authors:  Inga Bauer; Alessia Grozio; Denise Lasigliè; Giovanna Basile; Laura Sturla; Mirko Magnone; Giovanna Sociali; Debora Soncini; Irene Caffa; Alessandro Poggi; Gabriele Zoppoli; Michele Cea; Georg Feldmann; Raul Mostoslavsky; Alberto Ballestrero; Franco Patrone; Santina Bruzzone; Alessio Nencioni
Journal:  J Biol Chem       Date:  2012-10-18       Impact factor: 5.157

9.  Hexokinase II knockdown results in exaggerated cardiac hypertrophy via increased ROS production.

Authors:  Rongxue Wu; Eugene Wyatt; Kusum Chawla; Minh Tran; Mohsen Ghanefar; Markku Laakso; Conrad L Epting; Hossein Ardehali
Journal:  EMBO Mol Med       Date:  2012-04-20       Impact factor: 12.137

10.  Xanthine oxidoreductase regulates macrophage IL1β secretion upon NLRP3 inflammasome activation.

Authors:  Annette Ives; Johji Nomura; Fabio Martinon; Thierry Roger; Didier LeRoy; Jeffrey N Miner; Gregoire Simon; Nathalie Busso; Alexander So
Journal:  Nat Commun       Date:  2015-03-24       Impact factor: 14.919

View more
  7 in total

1.  Hexokinase 2 is a transcriptional target and a positive modulator of AHR signalling.

Authors:  Manon Watzky; Solène Huard; Ludmila Juricek; Julien Dairou; Caroline Chauvet; Xavier Coumoul; Anne Letessier; Benoit Miotto
Journal:  Nucleic Acids Res       Date:  2022-06-10       Impact factor: 19.160

Review 2.  Mechanisms of Long Non-Coding RNAs in Biological Characteristics and Aerobic Glycolysis of Glioma.

Authors:  Ningning Zhao; Jiajie Zhang; Qian Zhao; Chao Chen; Huijuan Wang
Journal:  Int J Mol Sci       Date:  2021-10-18       Impact factor: 5.923

3.  The metabolic enzyme hexokinase 2 localizes to the nucleus in AML and normal haematopoietic stem and progenitor cells to maintain stemness.

Authors:  Geethu Emily Thomas; Grace Egan; Laura García-Prat; Aaron Botham; Veronique Voisin; Parasvi S Patel; Fieke W Hoff; Jordan Chin; Boaz Nachmias; Kerstin B Kaufmann; Dilshad H Khan; Rose Hurren; Xiaoming Wang; Marcela Gronda; Neil MacLean; Cristiana O'Brien; Rashim P Singh; Courtney L Jones; Shane M Harding; Brian Raught; Andrea Arruda; Mark D Minden; Gary D Bader; Razq Hakem; Steve Kornblau; John E Dick; Aaron D Schimmer
Journal:  Nat Cell Biol       Date:  2022-06-06       Impact factor: 28.213

4.  Lipoprotein Deprivation Reveals a Cholesterol-Dependent Therapeutic Vulnerability in Diffuse Glioma Metabolism.

Authors:  James Wood; Salah Abdelrazig; Sergey Evseev; Catherine Ortori; Marcos Castellanos-Uribe; Sean T May; David A Barrett; Mohammed Diksin; Sajib Chakraborty; Dong-Hyun Kim; Richard G Grundy; Ruman Rahman
Journal:  Cancers (Basel)       Date:  2022-08-11       Impact factor: 6.575

5.  Rewiring of Lactate-Interleukin-1β Autoregulatory Loop with Clock-Bmal1: a Feed-Forward Circuit in Glioma.

Authors:  Pruthvi Gowda; Kirti Lathoria; Shalini Sharma; Shruti Patrick; Sonia B Umdor; Ellora Sen
Journal:  Mol Cell Biol       Date:  2021-08-24       Impact factor: 4.272

Review 6.  SRC Kinase in Glioblastoma News from an Old Acquaintance.

Authors:  Claudia Cirotti; Claudia Contadini; Daniela Barilà
Journal:  Cancers (Basel)       Date:  2020-06-12       Impact factor: 6.639

7.  Multiple-Purpose Connectivity Map Analysis Reveals the Benefits of Esculetin to Hyperuricemia and Renal Fibrosis.

Authors:  Yiming Wang; Weikaixin Kong; Liang Wang; Tianyu Zhang; Boyue Huang; Jia Meng; Baoxue Yang; Zhengwei Xie; Hong Zhou
Journal:  Int J Mol Sci       Date:  2020-10-18       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.